B Bilgin Global Mod Global Mod 14 Eyl 2023 #1 Intas eyes Biogen’s biosimilars for $1 bn Ahmedabad-based Intas is being advised by Goldman Sachs Group Inc. and has submitted a non-binding bid and is seeking to put a binding one later this month
Intas eyes Biogen’s biosimilars for $1 bn Ahmedabad-based Intas is being advised by Goldman Sachs Group Inc. and has submitted a non-binding bid and is seeking to put a binding one later this month
